The future of prostate cancer prevention

Annals of the New York Academy of Sciences

Volumn 952, Issue , 2001, Pages 145-152

  Brawley, Otis W ^a,b   Barnes, Shakia ^a   Parnes, Howard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 reductase inhibitor; Chemoprevention; Clinical trials; Prostate; Prostate cancer; Selenium; Vitamin A; Vitamin D; Vitamin E; tocopherol

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANDROGEN; ANTIOXIDANT; CALCITRIOL; CALCIUM; CRYPTOXANTHIN; EFLORNITHINE; FINASTERIDE; ISOTHIOCYANIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; POLYPHENOL; RETINOL; SELENIUM; SOYBEAN PROTEIN; STEROID 5ALPHA REDUCTASE INHIBITOR; SULINDAC; VITAMIN D;

CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

GLYCINE MAX;

EID: 0035687104     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb02735.x     Document Type: Conference Paper

References (48)

1. International trends and patterns of prostate cancer incidence and mortality
2. Insulin-like growth factors and cancer
3. Insulin-like growth factor-I and binding protein-3 and risk of cancer
4. What causes prostate cancer? A brief summary of the epidemiology
5. Tomatoes, lycopene, and prostate cancer
6. Selenium and risk of prostate cancer
7. Chemoprevention of prostate cancer: Concepts and strategies
8. Cancer chemoprevention
9. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians
10. Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial
11. Prostate Cancer Prevention Trial (PCPT) update
12. Finasteride dosedependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro
13. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells
14. Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning 83327 rat prostatic carcinoma
15. A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats
16. Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143
17. Chemoprevention of rat prostate carcinogenesis by use of finasteride or casodex
18. Clinical review: 67: Approach to chemoprevention of prostate cancer
19. Chemoprevention. CA
20. Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia
21. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: Results of a 2-year randomized controlled trial (the PROSPECT study). PROscar safety plus efficacy Canadian two year study
22. Serum prostatespecific antigen and prostate volume predict long-term changes in symptoms and flow rate: Results of a four-year, randomized trial comparing finasteride versus placebo
23. Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: Effects of finasteride
24. The effect of finasteride on prostate specific antigen: Review of available data
25. Prostate Cancer Prevention Trial (PCPT) update
26. Effect of early treatment of prostate cancer with the 5alpha-reductase inhibitor turosteride in Dunning 83327 prostatic carcinoma in rats
27. Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial
28. Immunohistochemical expression of pi class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride
29. Decreased incidence of prostate cancer with selenium supplementation: Results of a doubleblind cancer prevention trial
30. Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro
31. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
32. Experimental basis for cancer prevention by vitamin E
33. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
34. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
35. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study
36. Tomatoes, lycopene, and prostate cancer
37. Tomatoes, tomato-based products, lycopene, and prostate cancer: Review of the epidemiologic literature
38. Chemoprevention of prostate cancer: Guidelines for possible intervention strategies
39. Vitamin D and prostate cancer
40. Genistein inhibits NF-kappa B activation in prostate cancer cells
41. Prevention of spontaneous prostate-related cancer in lobundwistar rats by a soy protein isolate/isoflavone diet
42. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice
43. Nutritional and socioeconomic factors in relation to prostate cancer mortality: A cross-national study
44. Energy, nutrient intake and prostate cancer risk: A population-based case-control study in Sweden
45. Cancer of the prostate: A nutritional disease?
46. Chemoprevention of prostate cancer
47. Cancer chemoprevention. Part 2: Hormones, non-classic antioxidant natural agents, NSAIDs, and other agents
48. Low-dose difluoromethylornithine and polyamine levels in human prostate tissue